Stock Insights on PURE Bioscience (OTCMKTS:PURE)

0

PURE Bioscience (OTCMKTS:PURE) saw no recent moves in price and volume in the last trading day. PURE been on the move in recent months moving up off $0.78  lows to highs near $1.55.

This follows a number of positive developments including their announcement on November 3 they received an FDA Acknowledgement Letter for Use of SDC Antimicrobial as Fresh Produce Processing Aid; The Company Targets Q1 2016 for Commercialization of PURE Control(R) Into New $300+ Million Market Segment.

PURE Bioscience (OTCMKTS:PURE) is focused on developing and commercializing their proprietary antimicrobial products primarily in the food safety arena — providing solutions to the health and environmental challenges of pathogen and hygienic control. The Company is the creator of the patented silver dihydrogen citrate (SDC) antimicrobial.

PURE technology platform is based on patented stabilized ionic silver, and our initial products contain silver dihydrogen citrate, or SDC. SDC is a broad-spectrum, non-toxic antimicrobial agent, which offers 24-hour residual protection and formulates well with other compounds. As a platform technology, SDC is distinguished from existing products in the marketplace because of its superior efficacy, reduced toxicity and the inability of bacteria to form a resistance to it.

PURE Hard Surface disinfectant, which is powered by the patented, non-toxic, environmentally friendly SDC antimicrobial molecule, fits perfectly into SUBWAY(R)’s commitment to greener living and its food safety protocol. A leader in the quick service restaurant industry, all SUBWAY(R) restaurants are required to follow policies in support of SUBWAY(R)’s overall commitment to make its restaurants and operations as environmentally and socially responsible as possible. The availability of the powerful PURE Hard Surface disinfectant will strengthen the quick service restaurant chain’s sanitization program.

To Find out the inside Scoop on PURE Subscribe to Microcapdaily.com Right Now by entering your Email in the box below

On November 10 PURE said it has received an Acknowledgement Letter from the US Food and Drug Administration (FDA) for its Food Contact Notification (FCN) for Silver Dihydrogen Citrate (SDC) as a spray or dip on processed fruits and vegetables stating that its submission is complete and setting an effective date of January 2016.

PURE is prepared to begin commercialization of PURE Control in calendar Q1 2016 as a food safety solution for a broad range of processed vegetables and fruits that are most frequently associated with pathogen contamination. In its regulatory filing, PURE demonstrated materially significant reductions in Salmonella, Listeria and E. coli in processed fresh produce, as compared with current processing chemicals.

According to the Company they are engaged in both “push” and “pull” sales and marketing initiatives with produce processors, retailers, and distributors to prime demand for PURE Control. Among these are some of the very largest vegetable and fruit processors, grocery and restaurant chains.

On December 16 PURE reported financial results for the quarter ended October 31, 2016.

We analyze the earnings along side the following peers of PURE Bioscience, Inc. – Ecolab Inc., Ocean Bio-Chem, Inc., United-Guardian, Inc. and Calgon Carbon Corporation (ECL-US, OBCI-US, UG-US and CCC-US) that have also reported for this period.

Highlights

Summary numbers: Revenues of USD 0.53 million, Net Earnings of USD -1.74 million.
Gross margins narrowed from 70.97% to 50.09% compared to the same period last year, operating (EBITDA) margins now -288.51% from -973.66%.
Year-on-year change in operating cash flow of 17.04% is about the same as the change in earnings, likely no significant movement in accruals or reserves.
Earnings growth from operating margin improvements as well as one-time items.

We have a Monster Pick Coming. Subscribe Right Now!

Currently trading at a $59.71 million market valuation PURE does have $3.9 million in the treasury as well as some small revenues. PURE is an exciting story developing in small caps; the Company is the creator of the EPA and FDA approved, patented silver dihydrogen citrate (SDC) antimicrobial that has just announced several important milestones including received FDA approval for their SDC antimicrobial technology for use as a raw poultry processing aid and Attaining FDA approval as a direct food contact processing aid for fresh produce. PURE is also ex NASDAQ with runner in its blood and ready interest and liquidity. We will be updating on PURE as events unfold so make sure you are subscribed to Microcapdaily so you know what is going on with PURE.

Sign Up now for our 100% FREE Penny Stock Newsletter

Disclosure: we hold no position in PURE either long or short and we have not been compensated for this article.

Share.

Leave A Reply

Sign up now for our 100% FREE Penny Stock Newsletter

Privacy Policy. we will never share your email with anyone.